Results 11 to 20 of about 310,970 (312)

Guidance for the management of patients with latent tuberculosis infection requiring biologic therapy in rheumatology and dermatology clinical practice. [PDF]

open access: yes, 2015
Since the introduction of biologics for the treatment of rheumatoid arthritis (RA), psoriatic arthritis (PsA), ankylosing spondylitis (AS), and psoriasis (Pso) an increased risk of tuberculosis (TB) reactivation in patients with latent tuberculosis ...
Niccoli L   +11 more
core   +2 more sources

cheminfo/biologic-converter: v0.6.0

open access: yes, 2022
<a href="https://github.com/cheminfo/biologic-converter/compare/v0.5.0...v0.6.0">0.6.0</a> (2022-11-21) ⚠ BREAKING CHANGES <ul> <li>release refactored code</li> </ul> Features <ul> <li>release refactored ...
cheminfo-bot   +4 more
core   +1 more source

Psoriasis, biologic therapy, and the pandemic of the 21st century [PDF]

open access: yes, 2020
The pandemic known as coronavirus disease-19 (COVID-19) has quickly spread worldwide, with a significant impact on lives all over the world. The complexity related to the new coronavirus and the clinical syndrome it causes is not yet fully understood ...
Torres, Tiago   +2 more
core   +1 more source

Biologic treatments in Behçet’s disease

open access: yes, 2021
Behcet's disease (BD) significantly increases morbidity and mortality, especially in young men. While vascular involvement is the most frequent cause of mortality, ocular involvement, which can cause visual loss, is the most important cause of ...
Fatma Alibaz-Öner   +3 more
core   +1 more source

Impact of pre-biologic impairment on meeting domain-specific biologic responder definitions in patients with severe asthma [PDF]

open access: yes, 2023
BACKGROUND: There is little agreement on clinically useful criteria for identifying real-world responders to biologic treatments for asthma.OBJECTIVE: To investigate the impact of pre-biologic impairment on meeting domain-specific biologic responder ...
Tran, Trung N.   +190 more
core   +1 more source

First‐in‐human high‐cumulative‐dose stem cell therapy in idiopathic pulmonary fibrosis with rapid lung function decline

open access: yesStem Cells Translational Medicine, 2020
Previous phase I studies demonstrated safety and some beneficial effects of mesenchymal stem cells (MSCs) in patients with mild to moderate idiopathic pulmonary fibrosis (IPF).
Alexander Averyanov   +10 more
doaj   +1 more source

From ancient Egypt to the dermatologic office: An overview of skin substitutes and modern‐day applications in dermatologic surgery

open access: yesHealth Science Reports, 2023
Skin grafting (specifically xenografting) dates back to as early as 1500 before Christ (BC) in the Ebers papyrus, an Egyptian medical papyrus. In 1503, the use of human skin allograft was described in the manuscript of Branca of Sicily, and among the ...
Alison Tran   +2 more
doaj   +1 more source

Dual Biologic Therapy in Patients with Familial Mediterranean Fever and Spondyloarthritis: Case-Based Review

open access: yes, 2023
Patients with familial Mediterranean fever and spondylitis often fail to respond to conventional and biologic therapies. Achieving remission in these patients usually requires conventional and biologic treatment combinations.
İbrahim Vasi   +19 more
core   +1 more source

Biological information [PDF]

open access: yesTheory in Biosciences, 2020
AbstractIn computer science, we can theoretically neatly separate transmission and processing of information, hardware and software, and programs and their inputs. This is much more intricate in biology. Nevertheless, I argue that Shannon’s concept of information is useful in biology, although its application is not as straightforward as many people ...
openaire   +4 more sources

Factors Associated with Multi-Biologic Use in Psoriasis Patients at an Academic Medical Center and Review of Biologic Survival. [PDF]

open access: yes, 2023
BACKGROUND: Despite their impressive efficacy in phase 3 trials, biologic agents for psoriasis (PsO) may lose efficacy over time. The factors associated with loss of efficacy have yet to be fully elucidated.
Mosca, Megan   +16 more
core   +1 more source

Home - About - Disclaimer - Privacy